Literature DB >> 31403466

X-tra X: An escape to autoimmunity.

Gregory F Wu.   

Abstract

Identifying the factors driving disease disparities between males and females with multiple sclerosis (MS) holds great promise for deciphering immunopathogenic disease mechanisms. In this issue of JCI, Itoh et al. explore the basis for sexual dimorphism in autoimmunity, specifically in MS. Using the experimental autoimmune encephalomyelitis (EAE) model of MS, which recapitulates CD4+ T cell-dependent disease, the authors examined the contribution of Kdm6a, a histone demethylase gene known to escape X inactivation. Conditional knockout in CD4+ T cells revealed Kdm6a involvement with a collection of immunologic processes having the potential to skew immunity toward inflammatory responses. This study concisely shows the value of X chromosome gene expression in T cell regulation of autoimmunity and the relevance of Kdm6a in the pathogenesis of EAE as a model of MS.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31403466      PMCID: PMC6715375          DOI: 10.1172/JCI130312

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

Review 1.  Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics.

Authors:  Nicolas Collongues; Christine Patte-Mensah; Jérôme De Seze; Ayikoe-Guy Mensah-Nyagan; Tobias Derfuss
Journal:  Expert Rev Neurother       Date:  2018-06-06       Impact factor: 4.618

2.  Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.

Authors:  Virginia Devonshire; Eva Havrdova; Ernst Wilhelm Radue; Paul O'Connor; Lixin Zhang-Auberson; Catherine Agoropoulou; Dieter Adrian Häring; Gordon Francis; Ludwig Kappos
Journal:  Lancet Neurol       Date:  2012-04-10       Impact factor: 44.182

Review 3.  Sexual disparities in the incidence and course of MS.

Authors:  Riley Bove; Tanuja Chitnis
Journal:  Clin Immunol       Date:  2013-03-22       Impact factor: 3.969

Review 4.  X chromosome inactivation and autoimmunity.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 5.  Sexual dimorphism in autoimmune disease.

Authors:  P A McCombe; J M Greer; I R Mackay
Journal:  Curr Mol Med       Date:  2009-12       Impact factor: 2.222

6.  Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis.

Authors:  Despoina Manousaki; Tom Dudding; Simon Haworth; Yi-Hsiang Hsu; Ching-Ti Liu; Carolina Medina-Gómez; Trudy Voortman; Nathalie van der Velde; Håkan Melhus; Cassianne Robinson-Cohen; Diana L Cousminer; Maria Nethander; Liesbeth Vandenput; Raymond Noordam; Vincenzo Forgetta; Celia M T Greenwood; Mary L Biggs; Bruce M Psaty; Jerome I Rotter; Babette S Zemel; Jonathan A Mitchell; Bruce Taylor; Mattias Lorentzon; Magnus Karlsson; Vincent V W Jaddoe; Henning Tiemeier; Natalia Campos-Obando; Oscar H Franco; Andre G Utterlinden; Linda Broer; Natasja M van Schoor; Annelies C Ham; M Arfan Ikram; David Karasik; Renée de Mutsert; Frits R Rosendaal; Martin den Heijer; Thomas J Wang; Lars Lind; Eric S Orwoll; Dennis O Mook-Kanamori; Karl Michaëlsson; Bryan Kestenbaum; Claes Ohlsson; Dan Mellström; Lisette C P G M de Groot; Struan F A Grant; Douglas P Kiel; M Carola Zillikens; Fernando Rivadeneira; Stephen Sawcer; Nicholas J Timpson; J Brent Richards
Journal:  Am J Hum Genet       Date:  2017-07-27       Impact factor: 11.043

Review 7.  CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis.

Authors:  Sushmita Sinha; Alexander W Boyden; Farah R Itani; Michael P Crawford; Nitin J Karandikar
Journal:  Front Immunol       Date:  2015-12-10       Impact factor: 7.561

8.  Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation.

Authors:  Sugata Manna; Jong Kyong Kim; Catherine Baugé; Margaret Cam; Yongmei Zhao; Jyoti Shetty; Melanie S Vacchio; Ehydel Castro; Bao Tran; Lino Tessarollo; Rémy Bosselut
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

Review 9.  Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.

Authors:  Tanima Bose
Journal:  Brain Sci       Date:  2017-11-07

10.  Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

Authors:  Alessia Manni; Vita Direnzo; Antonio Iaffaldano; Valentina Di Lecce; Carla Tortorella; Stefano Zoccolella; Pietro Iaffaldano; Maria Trojano; Damiano Paolicelli
Journal:  Brain Behav       Date:  2017-08-29       Impact factor: 2.708

View more
  1 in total

Review 1.  X-factors in human disease: impact of gene content and dosage regulation.

Authors:  He Fang; Xinxian Deng; Christine M Disteche
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.